The new Kyoto guidelines offer evidence-based recommendations for diagnosing and treating intraductal papillary mucinous neoplasm (IPMN), emphasizing the role of endoscopic ultrasonography (EUS).
EUS is a high-resolution diagnostic tool that allows for detailed imaging and the collection of cyst fluid or tissue samples, making it essential for pancreatic disease diagnosis.
Recent studies show that EUS has over 90% sensitivity for detecting mural nodules, making it at least as effective as other imaging methods, while also highlighting the need for skilled endoscopists to ensure objective results.